In this video, Motley Fool health-care analyst David Williamson discusses what investors can expect from Celgene's (CELG +0.00%) upcoming earnings report and what to look for going forward.
Read Next
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.